NASDAQ: CMAXCaremax Inc Stock
$2.10-0.03 (-1.41%)
Updated Sep 20, 2023
CMAX Price
$2.10
Fair Value Price
N/A
Market Cap
$235.36M
52 Week Low
$1.83
52 Week High
$7.83
P/E
-1.83x
P/B
0.38x
P/S
0.48x
PEG
N/A
Dividend Yield
N/A
Revenue
$719.36M
Earnings
-$126.08M
Gross Margin
12.9%
Operating Margin
-14.92%
Profit Margin
-17.5%
Debt to Equity
0.84
Operating Cash Flow
-$84M
Beta
1.28
Next Earnings
Nov 7, 2023
Ex-Dividend
N/A
Next Dividend
N/A
CMAX Overview
CareMax, Inc. provides medical services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation. The company also provides CareOptimize, a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians in the United States. As of December 31, 2021, it operated 48 multi-specialty medical care centers in Florida, Tennessee, and New York. The company is headquartered in Miami, Florida.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CMAX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CMAX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CMAX is good value based on its book value relative to its share price (0.38x), compared to the US Health Information Services industry average (3.15x)
P/B vs Industry Valuation
CMAX is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more CMAX due diligence checks available for Premium users.
Be the first to know about important CMAX news, forecast changes, insider trades & much more!
CMAX News
Valuation
CMAX fair value
Fair Value of CMAX stock based on Discounted Cash Flow (DCF)
Price
$2.10
Fair Value
$2.61
Undervalued by
19.45%
CMAX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
CMAX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-1.83x
Industry
53.63x
Market
14.54x
CMAX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.38x
Industry
3.15x
CMAX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CMAX's financial health
Profit margin
Revenue
$224.4M
Net Income
-$32.4M
Profit Margin
-14.4%
CMAX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CMAX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.2B
Liabilities
$526.5M
Debt to equity
0.84
CMAX's short-term assets ($218.65M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CMAX's long-term liabilities ($428.40M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CMAX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$21.5M
Investing
-$2.9M
Financing
$34.9M
CMAX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
CMAX vs Health Information Service Stocks
Caremax Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.